Skip to content- XW0D Mouth and Pharynx
- XW0DX External
- XW0DX3 Maribavir Anti-infective
- XW0DX38 Introduction of Maribavir Anti-infective into Mouth and Pharynx, External Approach, New Technology Group 8
- XW0DX6 Lefamulin Anti-infective
- XW0DX66 Introduction of Lefamulin Anti-infective into Mouth and Pharynx, External Approach, New Technology Group 6
- XW0DX8 Uridine Triacetate
- XW0DX82 Introduction of Uridine Triacetate into Mouth and Pharynx, External Approach, New Technology Group 2
- XW0DXF Other New Technology Therapeutic Substance
- XW0DXF5 Introduction of Other New Technology Therapeutic Substance into Mouth and Pharynx, External Approach, New Technology Group 5
- XW0DXJ Quizartinib Antineoplastic
- XW0DXJ9 Introduction of Quizartinib Antineoplastic into Mouth and Pharynx, External Approach, New Technology Group 9
- XW0DXK Sabizabulin
- XW0DXK8 Introduction of Sabizabulin into Mouth and Pharynx, External Approach, New Technology Group 8
- XW0DXM Baricitinib
- XW0DXM6 Introduction of Baricitinib into Mouth and Pharynx, External Approach, New Technology Group 6
- XW0DXN SER-109
- XW0DXN9 Introduction of SER-109 into Mouth and Pharynx, External Approach, New Technology Group 9
- XW0DXR Fostamatinib
- XW0DXR7 Introduction of Fostamatinib into Mouth and Pharynx, External Approach, New Technology Group 7